Cuba, the communist nation justly famous for its superior cigars, will soon be known the world over for its lung cancer vaccine, too.

During a recent trade mission trip to Cuba, the Roswell Park Cancer Institute of Buffalo, New York, signed an agreement that will allow the institute to import a Cuban lung cancer vaccine called CimaVax.

"This vaccine is cheap to make, it is effective and it has no toxicity," said Kelvin Lee, the chief of immunology at Roswell Park Cancer Institute, according to Fox News Latino. "It will treat people with lung cancer and could potentially prevent cancer in people who don't already have it."

The potentially life saving drug was developed by the Cuban government-run Molecular Immunology Center in the 1990s. Although the drug has been noted by various medical and media organizations over the years, the success rate of the vaccine has been kept a closely guarded secret.

Talks of using CimaVax, which is still a long way from coming to a U.S. market, began back in 2011 when Roswell Park opened up an academic exchange with their Cuban medical colleagues.

Doctors at Roswell Park hope to get Food and Drug Administration approval needed in order to initiate clinical trials within eight months. Once that occurs, they hope to partner up with a private company in order to develop the drug for U.S. patients.

Cuban scientists plan on visiting Buffalo to help with the testing as well as the research.

Candace Johnson, the director of the institute, said "The goal is to test it safely and ethically here in the U.S."

In Cuba CimaVax is already on the market and has treated around 1,000 people for lung cancer, around the globe the vaccine has been used on a total of 5,000 patients.